These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 30932300

  • 21. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P, Rumyantsev V.
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [Abstract] [Full Text] [Related]

  • 22. Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study.
    Ikuta K, Ito H, Takahashi K, Masaki S, Terauchi M, Suzuki Y.
    Int J Hematol; 2019 Jan; 109(1):50-58. PubMed ID: 30194568
    [Abstract] [Full Text] [Related]

  • 23. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA, Keating GM.
    Drugs; 2009 Jan; 69(6):739-56. PubMed ID: 19405553
    [Abstract] [Full Text] [Related]

  • 24. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment.
    Pollock RF, Muduma G.
    Expert Rev Hematol; 2019 Feb; 12(2):129-136. PubMed ID: 30689458
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P, Banké-Bochita J.
    Arzneimittelforschung; 2010 Feb; 60(6a):362-72. PubMed ID: 20648928
    [Abstract] [Full Text] [Related]

  • 26. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
    Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A.
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
    [Abstract] [Full Text] [Related]

  • 27. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    Mahey R, Kriplani A, Mogili KD, Bhatla N, Kachhawa G, Saxena R.
    Int J Gynaecol Obstet; 2016 Apr; 133(1):43-8. PubMed ID: 26868063
    [Abstract] [Full Text] [Related]

  • 28. Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients.
    Hofman JMG, Eisenga MF, Diepenbroek A, Nolte IM, van Dam B, Westerhuis R, Bakker SJL, Franssen CFM, Gaillard CAJM.
    BMC Nephrol; 2018 Sep 20; 19(1):242. PubMed ID: 30236065
    [Abstract] [Full Text] [Related]

  • 29. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
    Kim YH, Chung HH, Kang SB, Kim SC, Kim YT.
    Acta Haematol; 2009 Sep 20; 121(1):37-41. PubMed ID: 19332985
    [Abstract] [Full Text] [Related]

  • 30. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
    Charytan C, Bernardo MV, Koch TA, Butcher A, Morris D, Bregman DB.
    Nephrol Dial Transplant; 2013 Apr 20; 28(4):953-64. PubMed ID: 23222534
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana - An interventional study.
    Kant S, Kaur R, Ahamed F, Singh A, Malhotra S, Kumar R.
    Indian J Public Health; 2020 Apr 20; 64(2):168-172. PubMed ID: 32584300
    [Abstract] [Full Text] [Related]

  • 32. Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding.
    Ballester-Clau R, Torres Vicente G, Voltà-Pardo T, López-Barroso L, Cucala-Ramos M, Reñé-Espinet JM, Planella de Rubinat M.
    Eur J Gastroenterol Hepatol; 2019 Jan 20; 31(1):116-122. PubMed ID: 30335628
    [Abstract] [Full Text] [Related]

  • 33. Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.
    Bertani L, Tricò D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, Bellini M, Antonioli L, Blandizzi C, Marchi S.
    Nutrients; 2021 Feb 12; 13(2):. PubMed ID: 33673371
    [Abstract] [Full Text] [Related]

  • 34. Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department.
    Motta I, Mantovan G, Consonni D, Brambilla AM, Materia M, Porzio M, Migone De Amicis M, Montano N, Cappellini MD.
    Intern Emerg Med; 2020 Jun 12; 15(4):629-634. PubMed ID: 31707563
    [Abstract] [Full Text] [Related]

  • 35. Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France.
    Toledano A, Luporsi E, Morere JF, Scotté F, Laribi K, Barrière J, Huot-Marchand P, Duvillié L, Concas VH, Bugat R.
    Support Care Cancer; 2016 Jan 12; 24(1):67-75. PubMed ID: 25921449
    [Abstract] [Full Text] [Related]

  • 36. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
    Bisbe E, Moltó L, Arroyo R, Muniesa JM, Tejero M.
    Br J Anaesth; 2014 Sep 12; 113(3):402-9. PubMed ID: 24780615
    [Abstract] [Full Text] [Related]

  • 37. A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom.
    Pollock RF, Muduma G.
    J Med Econ; 2020 Jul 12; 23(7):751-759. PubMed ID: 32208038
    [Abstract] [Full Text] [Related]

  • 38. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
    Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A.
    Clin Nephrol; 2014 Jun 12; 81(6):419-26. PubMed ID: 24691014
    [Abstract] [Full Text] [Related]

  • 39. Effects of a multifaceted intervention to promote the use of intravenous iron sucrose complex instead of ferric carboxymaltose in patients admitted for more than 24 h.
    Touchard J, Perrin G, Berdot S, Pouchot J, Loustalot MC, Sabatier B.
    Eur J Clin Pharmacol; 2021 Feb 12; 77(2):189-195. PubMed ID: 32926203
    [Abstract] [Full Text] [Related]

  • 40. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose.
    Sobrado CW, Cançado RD, Sobrado LF, Frugis MO, Sobrado MF.
    Arq Gastroenterol; 2015 Dec 12; 52(4):255-9. PubMed ID: 26840464
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.